Atriva Therapeutics
T├╝bingen
About Atriva Therapeutics
Atriva Therapeutics is a biopharmaceutical company which aims to develop new antiviral therapies against different respiratory viral infections. Atriva Therapeutics completed preclinical development of ATR-002 and recently filed a request for scientific advice from a European regulatory authority to provide guidance on the executed preclinical development program and the planned ATR-002 Phase I study in healthy volunteers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.1M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Aug 2020)
- Website: atriva-therapeutics.com
- Phone: +4970718597673
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/atriva-therapeutics-973 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.